Pre-exposure Prophylaxis Use by Breastfeeding HIV-Uninfected Women: A Prospective Short-Term Study of Antiretroviral Excretion in Breast Milk and Infant Absorption

scientific article

Pre-exposure Prophylaxis Use by Breastfeeding HIV-Uninfected Women: A Prospective Short-Term Study of Antiretroviral Excretion in Breast Milk and Infant Absorption is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1371/JOURNAL.PMED.1002132
P3181OpenCitations bibliographic resource ID3324545
P932PMC publication ID5038971
P698PubMed publication ID27676257

P50authorCraig W HendrixQ59688777
Mark A MarzinkeQ88268174
Kenneth K MugwanyaQ88429175
Timothy R MuwongeQ88429177
Gabriel MuthuriQ88429179
Jared M BaetenQ89443633
Kenneth NgureQ89958961
Nelly MugoQ90832458
Elly KatabiraQ30905495
Connie CelumQ42571941
Grace John-StewartQ47146705
P2093author name stringAndy Stergachis
Nulu B Semiyaga
P2860cites workIncident HIV infection in pregnant and lactating women and its effect on mother-to-child transmission in South AfricaQ83600075
Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with MenQ24612082
Incident HIV during pregnancy and postpartum and risk of mother-to-child HIV transmission: a systematic review and meta-analysisQ27010727
Antiretroviral prophylaxis for HIV prevention in heterosexual men and womenQ28270788
Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study GroupQ29614934
Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in BotswanaQ29620078
Pharmacokinetics of tenofovir in breast milk of lactating rhesus macaquesQ33770127
Drug therapy for breast-feeding womenQ33966064
A novel index for expressing exposure of the infant to drugs in breast milkQ34346533
Is infant exposure to antiretroviral drugs during breastfeeding quantitatively important? A systematic review and meta-analysis of pharmacokinetic studiesQ34470986
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 InfectionQ34503668
Concentrations of tenofovir and emtricitabine in breast milk of HIV-1-infected women in Abidjan, Cote d'Ivoire, in the ANRS 12109 TEmAA Study, Step 2Q34737231
Pharmacokinetics and safety of single oral doses of emtricitabine in human immunodeficiency virus-infected childrenQ35005470
Drug excretion into breast milk--overviewQ35111467
Increased risk of HIV-1 transmission in pregnancy: a prospective study among African HIV-1-serodiscordant couplesQ35214337
Integrated Delivery of Antiretroviral Treatment and Pre-exposure Prophylaxis to HIV-1-Serodiscordant Couples: A Prospective Implementation Study in Kenya and UgandaQ36110276
Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trialQ36426896
Population pharmacokinetics of emtricitabine in human immunodeficiency virus type 1-infected pregnant women and their neonatesQ37115730
Antiretroviral concentrations in breast-feeding infants of mothers receiving highly active antiretroviral therapyQ37115759
Pharmacokinetics and safety of tenofovir in HIV-infected women during labor and their infants during the first week of lifeQ37551251
Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective studyQ38880362
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue9
P407language of work or nameEnglishQ1860
P921main subjectbreastfeedingQ174876
anti-retroviral agentQ50430310
P304page(s)e1002132
P577publication date2016-09-27
P1433published inPLOS MEDICINEQ1686921
P1476titlePre-exposure Prophylaxis Use by Breastfeeding HIV-Uninfected Women: A Prospective Short-Term Study of Antiretroviral Excretion in Breast Milk and Infant Absorption
P478volume13

Reverse relations

cites work (P2860)
Q40051192A Missed Opportunity for U.S. Perinatal Human Immunodeficiency Virus Elimination: Pre-exposure Prophylaxis During Pregnancy
Q38672579A Review of HIV Pre-Exposure Prophylaxis: The Female Perspective
Q64118054Canadian guideline on HIV preexposure prophylaxis and nonoccupational postexposure prophylaxis for pharmacists
Q38787423Consensus statement: Supporting Safer Conception and Pregnancy For Men And Women Living with and Affected by HIV.
Q40116624Delivering PrEP to pregnant and breastfeeding women in sub-Saharan africa: The implementation science frontier
Q92489546Emerging evidence from a systematic review of safety of pre-exposure prophylaxis for pregnant and postpartum women: where are we now and where are we heading?
Q92352371Evaluating the vertical HIV transmission risks among South African female sex workers; have we forgotten PMTCT in their HIV programming?
Q64882362Guidelines to support HIV-affected individuals and couples to achieve pregnancy safely: Update 2018.
Q91909107HIV seroconversion during pregnancy and the need for pre-exposure prophylaxis (PrEP)
Q54260529Increased Risk of Female HIV-1 Acquisition Throughout Pregnancy and Postpartum: A Prospective Per-coital Act Analysis Among Women with HIV-1 Infected Partners.
Q96308241Influences on willingness to use vaginal or oral HIV PrEP during pregnancy and breastfeeding in Africa: the multisite MAMMA study
Q38657474Low HIV incidence in pregnant and postpartum women receiving a community-based combination HIV prevention intervention in a high HIV incidence setting in South Africa
Q47575321Management of Pregnant Women and Children: Focusing on Preventing Mother-to-Infant Transmission.
Q99555977Mitochondrial DNA Parameters in Blood of Infants Receiving Lopinavir/Ritonavir or Lamivudine Prophylaxis to Prevent Breastfeeding Transmission of HIV-1
Q38737364Offering pre-exposure prophylaxis for HIV prevention to pregnant and postpartum women: a clinical approach
Q91852199Perceptions of HIV Preexposure Prophylaxis Among Young Pregnant Women from Rural KwaZulu-Natal, South Africa
Q50138591Plasma and breast milk pharmacokinetics of emtricitabine, tenofovir and lamivudine using dried blood and breast milk spots in nursing African mother-infant pairs
Q64119518PrEP Implementation for Mothers in Antenatal Care (PrIMA): study protocol of a cluster randomised trial
Q61798882PrEP uptake preferences among men who have sex with men in China: results from a National Internet Survey
Q33766562Pre-exposure prophylaxis for HIV prevention in women: current perspectives
Q64067207Retest and treat: a review of national HIV retesting guidelines to inform elimination of mother-to-child HIV transmission (EMTCT) efforts
Q53682339Risk perception and sex behaviour in pregnancy and breastfeeding in high HIV prevalence settings: Programmatic implications for PrEP delivery.
Q38750453Safety of oral tenofovir disoproxil fumarate-based HIV pre-exposure prophylaxis use in lactating HIV-uninfected women
Q58765180Scale up of PrEP integrated in public health HIV care clinics: a protocol for a stepped-wedge cluster-randomized rollout in Kenya
Q47551255Simultaneous quantification of four antiretroviral drugs in breast milk samples from HIV-positive women by an ultra-high performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) method
Q36146022Tenofovir Pre-exposure Prophylaxis for Pregnant and Breastfeeding Women at Risk of HIV Infection: The Time is Now.
Q56910156Tenofovir and tenofovir-diphosphate concentrations during pregnancy among HIV-uninfected women using oral preexposure prophylaxis
Q42271267Top Questions in ID: Pre-exposure Prophylaxis for HIV.

Search more.